This report summarizes the key findings from presentations on cell-based therapies, including CAR-T and CAR-NK therapies, at the EULAR 2025 Congress. The summaries are based exclusively on the content of the provided abstract book and are organized by disease.
Keep reading with a 7-day free trial
Subscribe to Drug Development Executive to keep reading this post and get 7 days of free access to the full post archives.